Journals / KONURALP TIP DERGİSİ / 2017 / Cilt: 9 - Sayı: 2

The Relation of Socio-Demographic and Clinical Factors to Depression and Anxiety Levels in Diabetic Patients

Diyabetik ve Non-diyabetik Kişilerde Sosyo-Demografik ve Klinik Faktörlerin Depresyon ve Anksiyete Düzeyleri ile İlişkisi

Pages
19–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings revealed socio-demographic rather than diabetes related factors to be important correlates of anxiety and depression among patients with diabetes and thereby no difference between diabetics and controls in terms of depression and anxiety levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the prevalence of anxiety and depression in diabetic versus non-diabetic persons in relation to socio-demographic and clinical risk factorsMethods: A total of 217 patients with type 2 diabetes mellitus (mean(SD) age: 53.7(8.1) years, 56.7% were females) and 100 age-matched non-diabetic control subjects (mean(SD) age: 36.9(10.6) years, 67.0% were females) were included in this cross-sectional questionnaire based survey.
📊
Key Findings & Data:Hospital Anxiety and Depression Scale (HADS) subscale scores for anxiety (HADS-A) and depression (HADS-D) were evaluated in diabetic patients in comparison to non-diabetics as well as in relation to socio-demographic and diabetes related characteristics.Results: Similar prevalence of anxiety and depression was noted in diabetic (42.4% and 35.5%, respectively) and non-diabetic (49.0% and 39%, respectively) groups.
💡
Conclusion & Impact:Conclusion: Our findings revealed socio-demographic rather than diabetes related factors to be important correlates of anxiety and depression among patients with diabetes and thereby no difference between diabetics and controls in terms of depression and anxiety levels.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Anksiyete · depresyon · diyabetik komplikasyonlar

Abstract

Objective: To determine the prevalence of anxiety and depression in diabetic versus non-diabetic persons in relation to socio-demographic and clinical risk factorsMethods: A total of 217 patients with type 2 diabetes mellitus (mean(SD) age: 53.7(8.1) years, 56.7% were females) and 100 age-matched non-diabetic control subjects (mean(SD) age: 36.9(10.6) years, 67.0% were females) were included in this cross-sectional questionnaire based survey. Hospital Anxiety and Depression Scale (HADS) subscale scores for anxiety (HADS-A) and depression (HADS-D) were evaluated in diabetic patients in comparison to non-diabetics as well as in relation to socio-demographic and diabetes related characteristics.Results: Similar prevalence of anxiety and depression was noted in diabetic (42.4% and 35.5%, respectively) and non-diabetic (49.0% and 39%, respectively) groups. In the diabetic group, female gender (p<0.001 and p=0.009, respectively) and low income status (p=0.035 and p=0.025, respectively) were associated with higher scores for both HADS-A and HADS-D, while in the control group, both HADS-A and HADS-D scores were significantly higher in the younger age (<45 years, p=0.008 for each). Apart from significantly higher scores for HADS-A in diabetic patients in case of ≥1 diabetic complications (p=0.009), no significant difference in HADS scores was noted with respect to disease characteristics. Conclusion: Our findings revealed socio-demographic rather than diabetes related factors to be important correlates of anxiety and depression among patients with diabetes and thereby no difference between diabetics and controls in terms of depression and anxiety levels.

Özet

Amaç: Diyabetik ve non-diyabetik kişilerde anksiyete ve depresyon prevalansının sosyo-demografik ve klinik risk faktörleri ile ilişkili olarak belirlenmesi Yöntemler: Bu kesitsel ankete dayalı çalışmaya toplam 217 tip 2 diabet hastası (ortalama (SS) yaş: 53.7(8.1) yıl, %56.7’si kadın) ve non-diyabetik 100 sağlıklı kontrol (ortalama (SS) yaş: 36.9(10.6) yıl, %67.0’si kadın) dahil edildi. Hastane Anksiyete ve Depresyon Ölçeği (HADS) için anksiyete (HADS-A) ve depresyon (HADS-D) alt ölçek skorları sosyo-demografik ve diyabete ilişkin özellikler bağlamında diyabetik ve non-diyabetik hastalarda, değerlendirildi. Bulgular: Sınırda veya anormal anksiyete ve depresyon prevalansları açısından diyabetik (sırasıyla %42.4 ve %35.5) ve non-diyabetik (sırasıyla %49.0 ve %39.0) gruplar arasında anlamlı bir farklılık saptanmadı. Diyabetik grupta, kadın cinsiyeti (sırasıyla, p<0.001 ve p=0.009) ve düşük gelir düzeyi (sırasıyla, p=0.035 ve p=0.025) daha yüksek HADS-A ve HADS-D skorları ile ilişkili bulundu. Kontrol grubunda HADS-A ve HADS-D skorları gençlerde daha yüksekti (<45 yaş, her biri için p=0.008). Diyabetik hastalarda ≥1 diyabetik komplikasyon varlığında anlamlı şekilde daha yüksek bulunan HADS-A skorları (p=0.009) dışında, HADS skorlarında hastalık özelliklerine göre anlamlı bir farklılık saptanmadı. Sonuç: Sonuç olarak, bulgularımız diyabet hastalarında diyabete ilişkin faktörlerden ziyade sosyo-demografik faktörlerin anksiyete ve depresyon üzerine etkin değişkenler olduğunu ve bu bağlamda diyabet hastaları ve kontrol olguları arasında depresyon ve anksiyete düzeyleri açısından bir farklılık olmadığını göstermektedir.

🔖

Cite This Article

VURAL, R., ŞAHİNTÜRK, Y., BOYLUBAY, Ş. M., YILMAZ, Ü., KULAKSIZOĞLU, B., YEŞİL, B., ÜNAL, A., ADAKAN, F. Y. (2017). The Relation of Socio-Demographic and Clinical Factors to Depression and Anxiety Levels in Diabetic Patients. KONURALP TIP DERGİSİ, Cilt: 9 - Sayı: 2, 19–28. https://ajindex.com/articles/205169

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
  2. International Diabetes Federation (IDF). The Global Burden. [Online] February 2014;6. URL:
  3. Satman I, Yilmaz T, Sengul A, et al., The TURDEP Group. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6
  4. Satman I, Omer B, Tutuncu Y, et al., TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169-80
  5. Koç EM, Başer DA, Özkara A ve ark. Diyabet Tanısıyla İzlenen Hastalarda Yaşam Kalitesi ve İlişkili Faktörlerin İncelenmesi: Türkiye İçin Bir Pilot Çalışma. Konuralp Tıp Dergisi, 2015, 2015.2: 76-82
  6. Khuwaja AK, Lalani S, Dhanani R, Azam IS, Rafique G, White F. Anxiety and depression among outpatients with type 2 diabetes: a multi-centre study of prevalence and associated factors. Diabetol Metab Syndr 2010;2:72
  7. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med 2009;26:153-61
  8. Nichols l, Barton PL, Glazner J, McCollum M. Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff Resour Alloc 2007;5:4
  9. Khowaja LA, Khuwaja AK, Cosgrove P: Cost of diabetes care in out-patient clinics of Karachi, Pakistan. BMC Health Serv Res 2007; 21:189
  10. Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010;33:264-69. 11. van Dijk SE, Pols AD, Adriaanse MC, et al. Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial. BMC Psychiatry 2013;13:128
  11. Pouwer F. Should we screen for emotional distress in type 2 diabetes mellitus? Nat Rev Endocrinol 2009;5:665-71
  12. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-85
  13. Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationship across the full range of symptom severity. Diabetes Care 2007;30:22